Top Clean Energy Stocks To Buy For 2019

tags:MITK,SIGM,PODD,BSL,ATLC,REIS,

Quick Take

Bloom Energy (BE) intends to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement.

The firm provides a new means of generating clean energy from renewable sources, delivering on-site electricity for organizations worldwide.

BE is seeking cheaper public capital as it plans to continue scaling its corporate offerings.

When we learn further details from management about IPO pricing and valuation, I'll provide a final opinion.

Company & Technology

The Sunnyvale, California-based company was founded in 2001 to change the way the world generates and consumes energy by converting fuels into electricity, without combustion.

Top Clean Energy Stocks To Buy For 2019: Mitek Systems, Inc.(MITK)

Advisors' Opinion:

• [By Brian Feroldi, Leo Sun, and Demitrios Kalogeropoulos]

  So, which stocks are potential hidden winners that can be safely purchased today? We asked a team of investors to weigh in, and they picked Sogou (NYSE:SOGO), TJX Companies (NYSE:TJX), and Mitek Systems (NASDAQ:MITK). 

• [By Shane Hupp]

  Mitek Systems Inc. (NASDAQ:MITK) Director Bruce Edward Hansen sold 40,000 shares of the stock in a transaction that occurred on Wednesday, May 30th. The stock was sold at an average price of $8.73, for a total transaction of $349,200.00. Following the completion of the sale, the director now owns 81,135 shares of the company’s stock, valued at approximately $708,308.55. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

• [By Shane Hupp]

  Paradigm Capital Management Inc. NY lifted its stake in shares of Mitek Systems, Inc. (NASDAQ:MITK) by 243.9% during the 2nd quarter, Holdings Channel reports. The firm owned 141,000 shares of the software maker’s stock after purchasing an additional 100,000 shares during the quarter. Paradigm Capital Management Inc. NY’s holdings in Mitek Systems were worth $1,255,000 at the end of the most recent reporting period.

• [By Motley Fool Staff]

  Many consumers prefer to deposit a check on their smartphone instead of visiting a bank branch or ATM in person. However, most banks lack the technological know-how to make this process work. That's why thousands of them have partnered with Mitek Systems (NASDAQ:MITK), a leading provider of image capture and identity verification software that makes it possible for banks to offer this must-have service to their customers.

• [By Max Byerly]

  ValuEngine downgraded shares of Mitek Systems (NASDAQ:MITK) from a buy rating to a hold rating in a report published on Friday.

  A number of other research analysts have also recently issued reports on MITK. BidaskClub upgraded Mitek Systems from a sell rating to a hold rating in a research report on Thursday, May 3rd. Zacks Investment Research upgraded Mitek Systems from a sell rating to a hold rating in a research report on Thursday, March 29th. Finally, National Securities assumed coverage on Mitek Systems in a research report on Friday, March 9th. They issued a buy rating and a $14.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has an average rating of Buy and an average target price of $12.00.

Top Clean Energy Stocks To Buy For 2019: Sigma Designs, Inc.(SIGM)

Advisors' Opinion:

• [By Ethan Ryder]

  These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

  Get Arcturus Therapeutics alerts: Don’t Miss This Stock: Arcturus Therapeutics Ltd. (ARCT),Issuer Direct Corporation (ISDR) (bitcoinpriceupdate.review) Blustering Stocks: Camtek Ltd. (NASDAQ:CAMT), Attis Industries, Inc. (NASDAQ:ATIS), Arcturus Therapeutics Ltd … (journalfinance.net) Digging Into the Earnings & Quant Data For These Shares: Arcturus Therapeutics Ltd. (NasdaqGM:ARCT), Lumber … (zeelandpress.com) Average True Range to Consider Before Investment Blink Charging Co. (NASDAQ:BLNK), Inuvo, Inc. (NYSE:INUV … (stocksnewspoint.com) Extremely Informative stocks: Sigma Designs, Inc. (NASDAQ:SIGM), Attis Industries, Inc. (NASDAQ:ATIS), Arcturus … (thestreetpoint.com)

  Shares of Arcturus Therapeutics stock traded up $0.05 during trading on Friday, hitting $8.10. 32,713 shares of the stock traded hands, compared to its average volume of 14,625. The firm has a market capitalization of $86.38 million, a PE ratio of -2.29 and a beta of 1.18. Arcturus Therapeutics has a 52 week low of $4.78 and a 52 week high of $15.19.

• [By Steve Symington]

  Data source: Silicon Laboratories.

  What happened with Silicon Labs this quarter? Revenue was above the high end of guidance provided in late January, which called for a range of $196 million to $202 million. On an adjusted (non-GAAP) basis, which excludes items like equity compensation and acquisition costs, net income was $38.3 million, or $0.87 per share -- also above guidance for adjusted earnings per share of between $0.73 and $0.79. IoT revenue grew 17% year over year to $103 million. Infrastructure revenue jumped 37% year over year to $49 million. Broadcast revenue declined 3% to $36 million. Access revenue fell 6% to $17 million. Subsequent to the end of the quarter, on April 18, 2018, Silicon Labs closed its $240 million acquisition of Sigma Designs' (NASDAQ:SIGM) Z-Wave business. Silicon Labs had initially agreed to acquire all of Sigma Designs this past December for $282 million, but amended the deal last quarter to include only its Z-Wave business after certain closing conditions weren't met. In any case, the purchase significantly expands Silicon Labs' position in mesh networking for smart homes. What management had to say

  Silicon Labs CEO Tyson Tuttle said:

Top Clean Energy Stocks To Buy For 2019: Insulet Corporation(PODD)

Advisors' Opinion:

• [By Todd Campbell]

  Systems from Insulet (NASDAQ:PODD) and Tandem Diabetes Care (NASDAQ:TNDM) are among those closest to competing against Medtronic. In Insulet's case, it's pairing up its popular OmniPod, a device that can be attached to the skin to deliver insulin for up to three days, with Dexcom's (NASDAQ:DXCM) popular G5 CGM, which charts blood glucose levels over time to provide greater insight. Tandem's combining its t:slim insulin pump with Dexcom's G5 CGM, too.

• [By Keith Speights]

  Dividend Yield

  Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88% AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97% Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29% DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77% Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57% Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14% Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22% Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61% Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82% Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64% Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

  Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.

• [By Todd Campbell]

  Medtronic is the only maker of an artificial pancreas right now, but other companies are developing their own closed-loop systems, and will launch them soon. Those closest to debuting them are the privately held Bigfoot Biomedical, Insulet (NASDAQ:PODD), and Tandem Diabetes Care (NASDAQ:TNDM). Bigfoot Biomedical is using Abbott's Freestyle Libre, while Insulet and Tandem Diabetes are using DexCom's CGMs.

• [By Brian Feroldi]

  Here's are some of the biggest and best-know publicly traded diabetes companies:

  Company Ticker Market Cap Products  Abbott Laboratories (NYSE: ABT) $126 billion Continuous glucose monitor AstraZeneca (NYSE: AZN) $95 billion Pharmaceuticals Becton, Dickinson (NYSE: BDX) $70 billion Diagnostic and delivery devices DexCom (NASDAQ:DXCM) $12.7  billion Continuous glucose monitor Eli Lilly (NYSE: LLY) $106 billion Insulin and pharmaceuticals Insulet   (NASDAQ:PODD) $6.1 billion Insulin pump Johnson & Johnson (NYSE: JNJ) $375 billion  Glucose monitor and pharmaceuticals Lexicon Pharmaceuticals (NASDAQ: LXRX) $1.2 billion Pharmaceuticals MannKind (NASDAQ: MNKD) $291 million Inhaled insulin Medtronic (NYSE: MDT) $133  billion Insulin pumps and continuous glucose monitor Novo Nordisk (NYSE:NVO) $116 billion Insulin and pharmaceuticals Sanofi (NYSE: SNY) $108 billion Insulin and pharmaceuticals Senseonics Holdings (NYSEMKT: SENS) $834 million Continuous glucose monitor

  DATA SOURCE: YAHOO! FINANCE. MARKET CAP DATA AS OF 9/25/2018. 

Top Clean Energy Stocks To Buy For 2019: Blackstone GSO Senior Floating Rate Term Fund(BSL)

Advisors' Opinion:

• [By Ethan Ryder]

  Media headlines about Blackstone/GSO Senior Fltg Rt Term Fund (NYSE:BSL) have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackstone/GSO Senior Fltg Rt Term Fund earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave media coverage about the company an impact score of 47.1154940270027 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

• [By Stephan Byrd]

  News articles about Blackstone/GSO Senior Fltg Rt Term Fund (NYSE:BSL) have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackstone/GSO Senior Fltg Rt Term Fund earned a daily sentiment score of 0.19 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.9711105753708 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

• [By Max Byerly]

  Press coverage about Blackstone/GSO Senior Fltg Rt Term Fund (NYSE:BSL) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Blackstone/GSO Senior Fltg Rt Term Fund earned a news impact score of 0.01 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 47.5730037272636 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

• [By Shane Hupp]

  News headlines about Blackstone/GSO Senior Fltg Rt Term Fund (NYSE:BSL) have been trending somewhat positive recently, Accern reports. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Blackstone/GSO Senior Fltg Rt Term Fund earned a media sentiment score of 0.00 on Accern’s scale. Accern also gave media headlines about the company an impact score of 47.30334299338 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top Clean Energy Stocks To Buy For 2019: Atlanticus Holdings Corporation(ATLC)

Advisors' Opinion:

• [By Money Morning Staff Reports]

  However, Seven Star's gains are already on the books. After looking at last week's top performing penny stocks, we'll show you a penny stock on the verge of jumping over 70%…

  Penny Stock Current Share Price Last Week's Gain Seven Stars Cloud Group Inc. (Nasdaq: SSC) $4.49 175.13% Alliance MMA Inc. (Nasdaq: AMMA) $0.37 121.05% India Globalization Capital Inc. (NYSE: IGC) $1.14 74.38% Obalon Therapeutics Inc. (Nasdaq: OBLN) $3.23 63.16% Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.56 55.76% Atlanticus Holdings Corp. (Nasdaq: ATLC) $2.85 43.55% Research Frontiers Inc. (Nasdaq: REFR) $1.28 41.37% Koss Corp. (Nasdaq: KOSS) $4.08 41.28% GLG Life Tech Corp. (TSE: GLG) $0.88 33.90% Geron Corp. (Nasdaq: GERN) $4.76 32.40%

  While those gains are already in the book, you don't have to miss out on the next penny stocks to soar.

Top Clean Energy Stocks To Buy For 2019: Reis, Inc(REIS)

Advisors' Opinion:

• [By Rich Smith]

  Shares of commercial real estate data provider Reis, Inc. (NASDAQ:REIS) soared 32.2% to close at $23 on the nose today, after Moody's Corporation (NYSE:MCO) announced it would acquire the company for (drumroll, please)...$23 a share!

• [By Shane Hupp]

  Emerald Expositions Events (NYSE: EEX) and Reis (NASDAQ:REIS) are both small-cap consumer discretionary companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

• [By Logan Wallace]

  Reis (NASDAQ:REIS) was upgraded by research analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Thursday.